Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminosol Gold is a branded intravenous amino acid solution produced by OSL Pharma, a pharmaceutical manufacturer based in Bangladesh. It is formulated to provide a comprehensive profile of essential and non-essential amino acids for patients requiring parenteral nutrition. The product is typically indicated for the prevention and treatment of nitrogen loss or for the provision of nutritional support in patients where the alimentary tract cannot be used, such as those with severe gastrointestinal disorders, extensive burns, or following major surgical procedures. The "Gold" designation likely refers to a specific concentration or an enriched formulation (e.g., with vitamins or electrolytes) tailored for specific metabolic needs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acids (OSL Pharma).